You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 30, 2025

Drug Price Trends for SULFACETAMIDE-SULFUR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SULFACETAMIDE-SULFUR

Average Pharmacy Cost for SULFACETAMIDE-SULFUR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SULFACETAMIDE-SULFUR 8-4% SUSP 69367-0245-16 0.10278 ML 2025-04-23
SULFACETAMIDE-SULFUR 9-4% CLSR 42192-0121-16 0.16003 ML 2025-04-23
SULFACETAMIDE-SULFUR 8-4% SUSP 58657-0469-16 0.10278 ML 2025-04-23
SULFACETAMIDE-SULFUR 10-5% CRM 58657-0468-01 1.44400 GM 2025-04-23
SULFACETAMIDE-SULFUR 8-4% SUSP 42192-0133-16 0.10278 ML 2025-04-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Sulfacetamide-Sulfur

Introduction

Sulfacetamide-sulfur is a topical medication commonly used to treat acne and dermatitis. This combination therapy leverages the antibacterial properties of sulfacetamide and the keratolytic and antibacterial effects of sulfur. Here, we will delve into the market analysis, price projections, and other relevant factors influencing this drug.

Market Demand and Usage

Clinical Use

Sulfacetamide-sulfur is widely used in dermatology for the treatment of acne and dermatitis. The combination is particularly valued for its ability to address patient sensitivities to dyes, fillers, preservatives, or other excipients found in commercially available products. This flexibility allows prescribers to customize the formulation to meet individual patient needs, which is a significant driver of demand[1].

Nominations and Regulatory Considerations

The Outsourcing Facilities Association and Sincerus have nominated sulfacetamide for inclusion on the 503B Bulks List, highlighting its importance in compounded medications. This nomination is supported by references from published peer-reviewed literature that describe the pharmacology and clinical use of sulfacetamide[1].

Pricing and Cost Analysis

Current Pricing

The cost of sulfacetamide-sulfur topical formulations varies widely depending on the concentration, dosage form, and quantity. Here are some examples:

  • 10%-5% Topical Liquid: Prices range from $68.81 for 170 grams to $376.96 for 227 grams[2].
  • 10%-5% Topical Lotion: Prices range from $96.35 for 170 grams to $368.65 for 60 grams[2].
  • 9%-4% Topical Suspension: Prices can be as high as $546.73 for 473 milliliters[2].

Factors Influencing Pricing

Several factors contribute to the variability in pricing:

  • Pharmacy and Location: Prices can differ significantly based on the pharmacy and location.
  • Stock Shortages: Stock shortages and other supply chain issues can lead to price fluctuations.
  • Dosage Form and Strength: Different concentrations and dosage forms result in varying prices.
  • Combination with Other APIs: The use of sulfacetamide in combination with other active pharmaceutical ingredients (APIs) can affect pricing due to the complexity of the formulation[1][2].

Market Trends and Projections

Sulfur Market Impact

The sulfur market, which is a critical component of the sulfacetamide-sulfur combination, is expected to grow significantly. Here are some key trends:

  • Global Demand: The sulfur market is projected to grow from 77.30 million metric tons in 2023 to 97.41 million metric tons by 2028, at a CAGR of 4.73%[3].
  • Fertilizer Industry: The fertilizer sector is a major driver, with sulfur being essential for enhancing soil fertility. This demand is particularly strong in the Asia-Pacific region[3].
  • Environmental Regulations: While stringent environmental regulations may hinder growth, the overall market outlook remains positive due to increasing demand from various industries[3].

Pharmaceutical Market

The pharmaceutical market, specifically the dermatology segment, also influences the demand for sulfacetamide-sulfur. The growing need for customized and effective treatments for acne and dermatitis drives the demand for this combination therapy.

Competitive Landscape

Key Players and Formulations

The market for sulfacetamide-sulfur includes various formulations and brands. Key players in the pharmaceutical industry that produce or distribute these products include outsourcing facilities and compounding pharmacies. The ability to customize formulations sets these players apart from traditional pharmaceutical companies[1].

Market Concentration

The market for sulfacetamide-sulfur is relatively fragmented, with multiple players offering different formulations. This fragmentation allows for a competitive pricing environment, which can benefit consumers but also introduces variability in pricing and availability[2].

Regulatory and Clinical Considerations

FDA Evaluations

The FDA's evaluation of sulfacetamide for inclusion on the 503B Bulks List is crucial for its continued use in compounded medications. This process involves a thorough review of historical and current use, as well as consultations with healthcare practitioners[1].

Clinical Evidence

The clinical use of sulfacetamide-sulfur is supported by a body of evidence from peer-reviewed literature. This evidence highlights its efficacy in treating acne and dermatitis, particularly in cases where patients have sensitivities to other ingredients[1].

Conclusion

The market for sulfacetamide-sulfur is driven by its clinical efficacy, the need for customized formulations, and the growing demand from the dermatology sector. While pricing can be variable due to several factors, the overall trend indicates a stable and growing market.

Key Takeaways

  • Clinical Use: Sulfacetamide-sulfur is widely used for treating acne and dermatitis, especially in cases of patient sensitivities.
  • Pricing Variability: Prices vary based on concentration, dosage form, and quantity, as well as pharmacy and location.
  • Market Growth: The sulfur market, a key component, is expected to grow at a CAGR of 4.73% from 2023 to 2028.
  • Regulatory Considerations: FDA evaluations and clinical evidence support the continued use of sulfacetamide in compounded medications.
  • Competitive Landscape: The market is fragmented, with multiple players offering customized formulations.

FAQs

What is the primary use of sulfacetamide-sulfur?

Sulfacetamide-sulfur is primarily used to treat acne and dermatitis, leveraging the antibacterial properties of sulfacetamide and the keratolytic and antibacterial effects of sulfur.

How does the pricing of sulfacetamide-sulfur vary?

Pricing varies based on the concentration, dosage form, quantity, pharmacy, and location. Stock shortages and other supply chain issues can also affect prices.

What is the projected growth of the sulfur market?

The sulfur market is expected to grow from 77.30 million metric tons in 2023 to 97.41 million metric tons by 2028, at a CAGR of 4.73%.

Why is sulfacetamide nominated for the 503B Bulks List?

Sulfacetamide is nominated for its use in treating acne and dermatitis, particularly in cases where patients have sensitivities to other ingredients, and for its potential to be compounded with other APIs.

What are the key drivers of the sulfur market?

The key drivers include the rising demand from the fertilizer manufacturing sector, increasing usage in rubber vulcanization, and growing demand from the chemical and pharmaceutical industries.

Sources

  1. Sulfacetamide sodium monohydrate - Report to assist the US Food and Drug Administration (FDA) in its evaluation of the use of sulfacetamide sodium monohydrate[1].
  2. Drugs.com - Sulfacetamide sodium/sulfur topical Prices, Coupons, Copay Cards[2].
  3. Mordor Intelligence - Sulfur Market Trends | Industry Analysis, Size & Outlook Report[3].
  4. Maximize Market Research - Sulfur Market: Global Industry Analysis And Forecast (2024-2030)[4].
  5. DrugBank - Sulfacetamide: Uses, Interactions, Mechanism of Action[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.